← FDA DRUG APPROVALS

FDA ANDA · ANDA214594

NORELGESTROMIN AND ETHINYL ESTRADIOL

Sponsor: ZYDUS PHARMS

APPLICATION
ANDA214594
TYPE
ANDA
ORIGINAL APPROVAL
2023-09-14
LATEST ACTION
2023-09-14
ROUTE
TRANSDERMAL
DOSAGE FORM
FILM, EXTENDED RELEASE
MARKETING STATUS
Prescription

Products

ETHINYL ESTRADIOL AND NORELGESTROMINPrescription
ETHINYL ESTRADIOL 0.035MG/24HR, NORELGESTROMIN 0.15MG/24HR · FILM, EXTENDED RELEASE · TRANSDERMAL

Approval history

2023-09-14UNKNOWN · Original · standardAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →